𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of a novel KRAS mutation identified in Noonan syndrome

✍ Scribed by Md. Abdur Razzaque; Yuta Komoike; Tsutomu Nishizawa; Kei Inai; Michiko Furutani; Toru Higashinakagawa; Rumiko Matsuoka

Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
384 KB
Volume
158A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Noonan syndrome (NS) is the most common non‐chromosomal syndrome seen in children and is characterized by short stature, dysmorphic facial features, chest deformity, a wide range of congenital heart defects and developmental delay of variable degree. Mutations in the Ras/mitogen‐activated protein kinase (MAPK) signaling pathways cause about 70% of NS cases with a KRAS mutation present in about 2%. In a cohort of 65 clinically confirmed NS patients of Japanese origin, we screened for mutations in the RAS genes by direct sequencing. We found a novel mutation in KRAS with an amino acid substitution of asparagine to serine at codon 116 (N116S). We analyzed the biological activity of this mutant by ectopic expression of wild‐type or mutant KRAS. NS‐associated KRAS mutation resulted in Erk activation and active Ras–GTP levels, and exhibited mild cell proliferation. In addition, kras‐targeted morpholino knocked‐down zebrafish embryos caused heart and craniofacial malformations, while the expression of mutated kras resulted in maldevelopment of the heart. Our findings implicate that N116S change in KRAS is a hyperactive mutation which is a causative agent of NS through maldevelopment of the heart. © 2012 Wiley Periodicals, Inc.

📜 SIMILAR VOLUMES

Expression studies of two novel in CIS-m
Expression studies of two novel in CIS-mutations identified in an intermediate case of Hunter syndrome
✍ Ricci, Verena ;Filocamo, Mirella ;Regis, Stefano ;Corsolini, Fabio ;Stroppiano, 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

## Abstract Hunter syndrome (Mucopolysaccharidosis type II) is a rare X‐linked recessive lysosomal storage disorder caused by the deficiency of the enzyme iduronate‐2‐sulfatase (IDS). To date, more than 200 different mutations have been reported in the IDS gene, located on Xq27.3–q28. Here, we repo

Novel recurrent nonsense mutation causin
Novel recurrent nonsense mutation causing neurofibromatosis type 1 (NF1) in a family segregating both NF1 and Noonan syndrome
✍ Bahuau, Michel; Houdayer, Claude; Assouline, Brigitte; Blanchet-Bardon, Claudine 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

Neurofibromatosis type 1 (NF1), a genetic disorder with neuroectodermal involvement, demonstrates phenotypic overlap in some patients with Noonan syndrome (NS), ultimately resulting in the so-called neurofibromatosis-Noonan syndrome (NF-NS). A strong association of the two phenotypic traits was rece